Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

<< Previous

Bullboard Posts

Next >>

Post by ScienceFirston Jul 05, 2023 8:38pm

272 Views

Post# 35528354

Valuation will catch up, one way or another

No matter how frustrating it can be for longs, I don't think we have nothing to be worried about the share price movement,

Given:

- how low we are with our valuation,
- how superior are our efficacy %s @90-days and @450-days versus competition
- where we are in this pivotal Ph. 2 (50% into it)
- how imminent is an FDA decision regarding Breakthrough designation

... anybody will want to ride it, no matter who they are as the upside is much higher than the downside. Soon, we'll have another major milestone that nobody will be able to ignore; FDA Breakthrough designation